NCT06594263

Brief Summary

The transition to parenthood is a critical period for both the woman and her partner, and this can affect the mental health of the parents. Like mothers, fathers are at risk of stress, anxiety, depression and post-traumatic stress disorder during the perinatal period. Existing screening or diagnostic tools have been developed on the basis of traditional depressive symptoms expressed by women. However, the manifestations of perinatal mental disorders appear to be different in men. It is therefore essential to develop tools that are sensitive and specific to both gender and the perinatal period in order to increase the sensitivity and specificity of screening for fathers. In France, to the best of the knowledge of the investigators, there is no validated tool in French to assess paternal psychological disorders, either prenatally or postnatally. Baldoni et al. had validated a brief self-report questionnaire, the " Perinatal Assessment of Paternal Affectivity " (PAPA), to screen for perinatal signs and symptoms of paternal affective disorder, using a gender-sensitive approach. The aim of this study is to cross-cultural adapt the PAPA in French and to evaluate its psychometric properties. This validation of the French-PAPA would provide a simple tool, easy to use in everyday practice, to detect any signs or symptoms of paternal psychopathological distress in the pre- and postnatal period.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
340

participants targeted

Target at P75+ for all trials

Timeline
6mo left

Started Oct 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Oct 2024Nov 2026

First Submitted

Initial submission to the registry

September 10, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

October 19, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 18, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 18, 2026

Last Updated

August 14, 2025

Status Verified

August 1, 2024

Enrollment Period

2 years

First QC Date

September 10, 2024

Last Update Submit

August 11, 2025

Conditions

Keywords

FathersPerinatalCross-cultural adaptationValidationDepressionAffective disordersScreening

Outcome Measures

Primary Outcomes (2)

  • French-PAPA

    Psychometric properties (acceptability, internal validity, validity of structure against external criteria) of the French version of the PAPA questionnaire

    0 day

  • Change of French-PAPA from baseline at 10 days

    Test-retest reliability of the French version of the PAPA questionnaire

    0 day, 10 days

Secondary Outcomes (6)

  • Hospital Anxiety and Depression Scale (HADS)

    0 day

  • Perceived Stress Scale - 10 items (PSS-10)

    0 day

  • General Health Questionnaire - 12 items (GHQ-12)

    0 day

  • Dyadic Adjustment Scale - 4 items (DAS-4)

    0 day

  • Socio-demographic and medical characteristics of male partners

    0 day

  • +1 more secondary outcomes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Women and their male partners whose wives have been consulted during the third trimester of pregnancy at the Clermont-Ferrand University Hospital Centre (France) or at one of the three private practices participating in the study and who wish to give birth at the Clermont-Ferrand University Hospital Centre and/or couples whose wives have given birth at the maternity unit of the Clermont-Ferrand University Hospital Centre.

You may qualify if:

  • Woman and its male partner aged 18 years old and older
  • Couple understanding, speaking and reading French
  • Couple giving their informed consent to participate voluntarily

You may not qualify if:

  • Woman without male partner
  • Woman admitted to intensive care after giving birth
  • Couple whose newborn died peripartum
  • Couple who have had a medical abortion or fetal death in utero for the current pregnancy
  • Woman and/or male partner refusing to participate in the study
  • Woman and/or male partner not speaking French
  • Woman and/or male partner in the incapacity to answer the questionnaires
  • Woman and/or male partner under guardianship or conservatorship, deprived of liberty, or in the custody of correctional authorities

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Clermont-Ferrand

Clermont-Ferrand, France

RECRUITING

MeSH Terms

Conditions

Mood DisordersDepression

Condition Hierarchy (Ancestors)

Mental DisordersBehavioral SymptomsBehavior

Study Officials

  • Françoise Vendittelli, PhD

    Clermont-Ferrand University Hospital Centre

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 10, 2024

First Posted

September 19, 2024

Study Start

October 19, 2024

Primary Completion (Estimated)

October 18, 2026

Study Completion (Estimated)

November 18, 2026

Last Updated

August 14, 2025

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations